Published in Panminerva Med on October 07, 2014
Vitamin D deficiency. N Engl J Med (2007) 59.34
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Collaborative care for patients with depression and chronic illnesses. N Engl J Med (2010) 8.92
Coordinating care--a perilous journey through the health care system. N Engl J Med (2008) 7.62
Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science (1991) 7.16
Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med (2011) 6.69
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet (1997) 4.95
Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst (2006) 4.91
Incidence of premature ovarian failure. Obstet Gynecol (1986) 4.64
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet (2001) 4.15
Clinical practice. Primary ovarian insufficiency. N Engl J Med (2009) 4.01
Improving patient care. The patient centered medical home. A Systematic Review. Ann Intern Med (2012) 3.90
The FMR1 premutation and reproduction. Fertil Steril (2006) 3.85
History of the medical home concept. Pediatrics (2004) 3.76
First FDA authorization for next-generation sequencer. N Engl J Med (2013) 3.70
Lay-led self-management in chronic illness: a review of the evidence. Chronic Illn (2006) 3.22
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation (2007) 3.17
The time is now for a new approach to primary ovarian insufficiency. Fertil Steril (2010) 3.15
Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev (2002) 3.13
Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod (2004) 3.01
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell (1995) 2.89
Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc (2008) 2.66
A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med (2008) 2.61
Continuity and the costs of care for chronic disease. JAMA Intern Med (2014) 2.47
Can 40 seconds of compassion reduce patient anxiety? J Clin Oncol (1999) 2.33
Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) (2007) 2.25
Academic health center management of chronic diseases through knowledge networks: Project ECHO. Acad Med (2007) 2.18
Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry (2012) 2.16
Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol (1999) 2.14
Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab (1998) 2.02
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med (2008) 2.01
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med (2005) 1.88
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet (2003) 1.88
Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet (1968) 1.83
Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab (2006) 1.81
Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet (2004) 1.72
Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol (2004) 1.69
Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol (Oxf) (2006) 1.68
The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol (1967) 1.64
Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol (2002) 1.58
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med (2013) 1.57
Effect of early menopause on bone mineral density and fractures. Menopause (2007) 1.53
Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab (1999) 1.52
Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet (2011) 1.51
A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet (1998) 1.50
Age at natural menopause and cause-specific mortality. Am J Epidemiol (2005) 1.44
The autoimmune regulator prevents premature reproductive senescence in female mice. Biol Reprod (2012) 1.42
FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med (2011) 1.42
Follicle dynamics during ovarian ageing. Mol Cell Endocrinol (2000) 1.40
Premature ovarian failure and ovarian autoimmunity. Endocr Rev (1997) 1.37
Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol (2000) 1.37
Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril (1982) 1.36
Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab (2004) 1.35
Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol (2002) 1.33
Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab (2009) 1.33
Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med (2013) 1.32
Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol (1980) 1.32
Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril (2005) 1.32
Genes involved in human premature ovarian failure. J Mol Endocrinol (2010) 1.29
Premature ovarian failure. Obstet Gynecol (2009) 1.27
Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril (2005) 1.26
ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol (2006) 1.23
Genes and translocations involved in POF. Am J Med Genet (2002) 1.23
Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med (1996) 1.21
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol (1997) 1.21
Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update (1999) 1.16
A family systems approach to primary ovarian insufficiency. J Pediatr Adolesc Gynecol (2011) 1.15
High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab (1995) 1.14
Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J Immunol (2006) 1.13
Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol (1971) 1.12
Perinatal oocyte loss in XO mice and its implications for the aetiology of gonadal dysgenesis in XO women. J Reprod Fertil (1985) 1.09
Physicians' satisfaction with a collaborative disease management program for late-life depression in primary care. Gen Hosp Psychiatry (2005) 1.07
The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health. Fertil Steril (2009) 1.05
Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J Clin Endocrinol Metab (2005) 1.04
Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA (2006) 1.04
The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause (2006) 1.03
The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function. Immunol Rev (2006) 1.02
Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab (1987) 1.00
Current evaluation of amenorrhea. Fertil Steril (2004) 0.99
Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol (2010) 0.98
Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab (1996) 0.98
The fertility potential of women with a single ovary. Hum Reprod Update (1999) 0.98
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin Exp Immunol (2004) 0.97
Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am (2002) 0.97
Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun (2012) 0.97
Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) (1993) 0.97
Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab (1994) 0.96
Premature ovarian failure. Obstet Gynecol (1985) 0.95
Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol (2005) 0.95
Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab (2014) 0.95
Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod (1997) 0.93
Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol (1987) 0.91
A new approach to primary ovarian insufficiency. Obstet Gynecol Clin North Am (2012) 0.91
Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health (2003) 0.91
Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol (1986) 0.90
The psychology of antecedents to adult reproductive disorders in adolescent girls. Ann N Y Acad Sci (2008) 0.90
Gonadal autoantibodies in patients with hypogonadism and/or Addison's disease. J Clin Endocrinol Metab (1981) 0.89
Autoimmune oophoritis. Am J Clin Pathol (1984) 0.88
Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet (2000) 2.73
A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab (1995) 2.22
Thyrotropin-secreting pituitary tumors. Endocr Rev (1996) 2.21
Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology (1993) 2.07
Effect of oxygen and nitrate on nitrogen fixation and denitrification by Azospirillum brasilense grown in continuous culture. Can J Microbiol (1978) 2.02
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol (2011) 1.90
Radiofrequency tonsil reduction. Arch Otolaryngol Head Neck Surg (2001) 1.88
A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology (1999) 1.87
Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol (1997) 1.73
Prenatal diagnosis of thyroid hormone resistance. J Clin Endocrinol Metab (1999) 1.67
Uptake hydrogenase activity and ATP formation in Rhizobium leguminosarum bacteroids. J Bacteriol (1982) 1.65
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol (1995) 1.58
Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol (1997) 1.53
Effect of starvation on survival of three bacterial isolates from an arctic soil. Can J Microbiol (1978) 1.49
Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod (2002) 1.45
Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab (1997) 1.44
Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy. J Exp Med (1990) 1.42
Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest (2000) 1.41
Recombinant interleukin-2: a biological response modifier. Clin Pharm (1991) 1.40
New hemodialysis membranes and vancomycin clearance. Am J Health Syst Pharm (1995) 1.40
Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy (2000) 1.39
International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int (1999) 1.39
Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler (2010) 1.36
Assessment of occupational exposures in community-based case-control studies. Annu Rev Public Health (1998) 1.35
Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol (1985) 1.30
Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet (1994) 1.24
Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke (1992) 1.21
The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology (1986) 1.15
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology (2005) 1.15
Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res (1995) 1.14
Hydrogen metabolism of Azospirillum brasilense in nitrogen-free medium. Can J Microbiol (1980) 1.13
Human ZP3 restores fertility in Zp3 null mice without affecting order-specific sperm binding. Development (1998) 1.10
Service use and costs for Medicare beneficiaries in risk-based HMOs and CMPs: some interim results from the National Medicare Competition Evaluation. Am J Public Health (1988) 1.10
Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol (1998) 1.09
Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol (1997) 1.07
Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro. Leukemia (2000) 1.07
The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol (1996) 1.07
Encephalitis caused directly by Mycoplasma pneumoniae. Scand J Infect Dis (1999) 1.07
Cognitive loss in multiple sclerosis. Case reports and review of the literature. Arch Neurol (1989) 1.05
Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology (2007) 1.05
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study. Ann Intern Med (1994) 1.04
Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev (1993) 1.02
Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy (1997) 1.02
Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry (1973) 1.01
Measurement of fat absorption using [3H]glycerol triether and [14C]glycerol trioleate in man. Clin Chim Acta (1980) 1.01
Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab (1997) 1.01
Functional and structural changes of the human proximal small intestine after cytotoxic therapy. J Clin Pathol (1985) 1.01
Nucleolar NF-κB/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin. Cell Death Differ (2011) 1.00
Premature ovarian failure. Endocrinol Metab Clin North Am (1998) 1.00
Cytokinin production by plant growth promoting rhizobacteria and selected mutants. Can J Microbiol (2001) 0.99
Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome. J Clin Endocrinol Metab (2000) 0.98
Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology (1990) 0.98
Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control study. Neuroepidemiology (1999) 0.97
A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol (1989) 0.97
Increased incidence of aberrant morphological phenotypes in human embryogenesis--an association with endometriosis. J Assist Reprod Genet (1995) 0.97
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab (2001) 0.96
Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology (1999) 0.96
Mater encodes a maternal protein in mice with a leucine-rich repeat domain homologous to porcine ribonuclease inhibitor. Mamm Genome (2000) 0.95
Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles. Hum Reprod (1998) 0.95
Randomized trial of leaving messages on telephone answering machines for control recruitment in an epidemiologic study. Am J Epidemiol (1996) 0.95
Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J Clin Endocrinol Metab (2003) 0.95
Cimetidine and prostaglandin: evidence for different modes of action on the rat gastric mucosa. Gastroenterology (1978) 0.94
Development of a questionnaire for detecting potential adverse drug reactions. Ann Pharmacother (1992) 0.93
Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis. Arch Phys Med Rehabil (1991) 0.93
Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab (1999) 0.93
Study design in genetic epidemiology: theoretical and practical considerations. J Natl Cancer Inst Monogr (1999) 0.93
Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy. J Vasc Interv Radiol (2000) 0.93
The effect of operative position on lumbar lordosis. A radiographic study of patients under anesthesia in the prone and 90-90 positions. Spine (Phila Pa 1976) (1995) 0.93
Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology (1988) 0.92
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects. J Clin Endocrinol Metab (2013) 0.92
Genetic defects of ovarian TGF-β-like factors and premature ovarian failure. J Endocrinol Invest (2011) 0.91
Neurology practice patterns in Colorado. Neurology (1987) 0.91
Vitamin A deficiency in Crohn's disease. Gut (1983) 0.91
Small-intestinal changes induced by an elemental diet (Vivonex) in normal rats. Clin Sci Mol Med (1978) 0.91
Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab (1996) 0.91
Premature ovarian failure is not premature menopause. Ann N Y Acad Sci (2000) 0.89
Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur J Endocrinol (1997) 0.88
Evaluation of bacteria isolated from rice for plant growth promotion and biological control of seedling disease of rice. Can J Microbiol (2001) 0.88
Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses (1991) 0.88
Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene. J Clin Endocrinol Metab (2001) 0.88
Glycoprotein hormone alpha-subunit in pituitary adenomas. Trends Endocrinol Metab (1992) 0.87
A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol (2001) 0.87
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis (1997) 0.86
Low birthweight infants and total parenteral nutrition immediately after birth. II. Randomised study of biochemical tolerance of intravenous glucose, amino acids, and lipid. Arch Dis Child Fetal Neonatal Ed (1995) 0.86
Treatment of autoimmune premature ovarian failure. Hum Reprod (1999) 0.86
Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome. Am J Med Genet (1999) 0.86
Inhibition of zona pellucida gene expression by antisense oligonucleotides injected into mouse oocytes. J Biol Chem (1995) 0.86
The genetic origins of ovarian failure. J Womens Health (1998) 0.85
Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions. Clin Exp Immunol (2010) 0.85
An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials. Neurogastroenterol Motil (2013) 0.85
Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus. Am J Hum Genet (1996) 0.85
Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab (1998) 0.85
Pharmacokinetics of vincristine in cancer patients treated with nifedipine. Cancer (1989) 0.85
Expression and biological effects of bone morphogenetic protein-15 in the hen ovary. J Endocrinol (2007) 0.84
Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab (2001) 0.84
Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. J Clin Psychopharmacol (2000) 0.84
Congenital hypothyroidism with gland in situ: diagnostic re-evaluation. J Endocrinol Invest (2005) 0.84
Thyroid gland development and function in the zebrafish model. Mol Cell Endocrinol (2009) 0.84
A study of zinc metabolism in alcoholic cirrhosis. Clin Sci (Lond) (1983) 0.84